US2015044210A1PendingUtilityA1
Modified microbial toxin receptor for delivering agents into cells
Est. expiryFeb 23, 2032(~5.6 yrs left)· nominal 20-yr term from priority
C07K 16/2863C07K 14/28C07K 14/25C07K 2319/75C07K 2319/33C07K 16/40C07K 14/33C07K 14/34C07K 2319/00C07K 2317/73C07K 14/21A61P 35/00C07K 2318/00C07K 16/32C07K 2319/55C07K 14/32
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
We described a novel system of targeted cell therapy with a protein toxin, such as anthrax toxin, that has been modified to re-direct it to a desired cell target instead of its natural cell target. The system can be used for, e.g., targeted killing of undesired cells in a population of cells, such as cancer or overly active immune system cells.
Claims
exact text as granted — not AI-modified1 . An altered binary toxin system for delivery of an active molecule to a target cell comprising:
a fusion protein comprising a receptor-ablated pore-forming AB toxin unit fused to a non-toxin-associated receptor-binding ligand specific for a target cell, and a complementary toxin unit capable of associating with the pore-forming toxin unit for delivery of a therapeutic protein to the cytosol of the target cell.
2 - 21 . (canceled)Join the waitlist — get patent alerts
Track US2015044210A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.